IRCT20190210042676N22 IRCT 2022-05-13 Tehran University of Medical Sciences Safety and efficacy of topical finasteride nanoemulgel 0.25% in the treatment of mild to moderate androgenetic alopecia Safety and efficacy of topical finasteride nanoemulgel 0.25% in the treatment of mild to moderate androgenetic alopecia on male and female pattern 2022-05-22 anticipated 40 Complete https://irct.ir/trial/63178 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2 hair loss. Intervention group: Treatment with topical finasteride nanoemulgel 0.25% in scalp area, once in a day for 24 weeks. This emulgel is prepared by high-speed homogenization method with nanoemulsion containing finasteride, which is prepared by materials such as lecithin, vitamin E, chloroform solvent, gelling, cholesterol, PEG 600 and distilled water.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information